![]() |
市場調查報告書
商品編碼
1938218
內視鏡膠囊市場 - 全球產業規模、佔有率、趨勢、機會及預測(按產品類型、配件、應用、最終用戶、地區和競爭格局分類),2021-2031年Endoscopy Capsule Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Accessories, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球內視鏡膠囊市場預計將從 2025 年的 8.2 億美元成長到 2031 年的 15.8 億美元,複合年成長率為 11.55%。
這些設備是無線、可吞嚥的裝置,配備微型鏡頭,能夠傳輸消化道(尤其是小腸)的圖像,並隨著人體自然的蠕動進行即時監測。推動此類設備發展的原因包括:克隆氏症和不明原因出血等胃腸道疾病的盛行率不斷上升,以及患者越來越傾向於選擇無需鎮靜的非侵入性檢測方法。美國癌症協會估計,2024年美國將新增152,810例大腸癌病例,凸顯了可靠篩檢工具的必要性,也顯示人們對便利診斷解決方案的需求日益成長。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 8.2億美元 |
| 市場規模:2031年 | 15.8億美元 |
| 複合年成長率:2026-2031年 | 11.55% |
| 成長最快的細分市場 | 冒號 |
| 最大的市場 | 北美洲 |
然而,由於檢測成本高昂和報銷政策波動,膠囊內視鏡市場面臨許多障礙,可能會阻礙其廣泛發展。在許多地區,膠囊內視鏡的保險覆蓋範圍比傳統光學內視鏡更為嚴格,這在對成本高度敏感的市場中造成了經濟障礙。因此,缺乏統一的財政支持迫使醫療服務提供者和患者依賴侵入性替代方法,限制了該技術成為全球標準治療方案的潛力。
人工智慧 (AI) 和機器學習的融合正在改變全球膠囊內視鏡市場,解決了影像分析耗時過長的難題。最新的演算法能夠快速處理膠囊運動過程中收集的數千張影像,並準確區分健康組織和潛在異常組織。這項技術進步不僅提高了診斷準確率,還減輕了胃腸病學家的負擔,並促進了膠囊內視鏡的大規模應用。作為這項進展的佐證,AnX Robotica 公司在 2024 年 1 月發布的新聞稿中宣布其 ProScan 設備獲得 FDA核准,並指出該公司的深度學習模型能夠以 99.88% 的靈敏度檢測出每位患者的小腸異常,這證實了人工智慧在改善胃腸病診療方面的重要作用。
同時,政府主導的癌症篩檢計畫正在推動市場成長,尤其是在那些力求縮短診斷等待時間的地區。公共衛生機構正日益將膠囊內視鏡納入國家通訊協定,將其作為比傳統大腸鏡檢查創傷更小的替代方案,從而提高患者接受度並實現早期發現。世界衛生組織(WHO)預測,到2024年,大腸癌將佔全球癌症病例的約9.6%,凸顯了此類便利篩檢方法的必要性。例如,英國科技新聞(UK Tech News)在2024年3月報道稱,西米德蘭茲郡的一項計劃旨在第一年為2000名患者使用結腸膠囊內視鏡技術,以加快診斷速度並縮短等待時間。
內視鏡膠囊市場擴張的主要障礙包括高昂的檢查費用和不均衡的保險報銷系統。雖然這項技術提供了一種非侵入性替代方案,但它通常缺乏傳統光學內視鏡所享有的全面保險覆蓋,這造成了經濟上的障礙,阻礙了其廣泛應用。醫療機構在獲得核准常常面臨挑戰,導致支付的不確定性,並加重了患者的負擔。這種經濟上的不平衡迫使醫療機構優先選擇具有檢驗計費代碼和支付保障的傳統方法,從而限制了膠囊技術的常規臨床應用。
這些財務壓力因胃腸道疾病相關服務的支付率下降而加劇,影響了新型診斷工具的商業性可行性。例如,美國胃腸病學會 (AGA) 報告稱,2024 年,美國醫療保險和醫療補助服務中心 (CMS) 將醫療保險醫師收費標準轉換係數降低了 3.37%,從而減少了胃腸內視鏡檢查的整體報銷額。這些資金削減阻礙了診所和注重預算的醫療系統實施膠囊內視鏡計畫。因此,由於經濟環境更傾向於成熟的、低成本的診斷方案,市場擴張受到阻礙。
磁控主動膠囊系統的出現正在改變市場格局,它克服了被動式設備在可視化複雜胃部解剖結構方面的限制。與依賴自然運動的標準膠囊不同,這些主動式系統利用外部磁鐵或內部推進裝置,使醫生能夠精準控制,無需鎮靜即可模擬胃鏡的操控性。這項創新吸引了大量資金流入,加速了可操控口腔機器人的研發。例如,根據《機器人報告》2024年6月報道,Start-UpsEndiatx已籌集700萬美元用於開發PillBot,這是一款能夠讓胃腸病學家遠端操控進行詳細胃部檢查的機器人。
同時,隨著居家和遠端膠囊內視鏡服務模式的興起,診斷正變得更加分散化。病患現在可以在家中而非診所進行檢查,從而減輕醫院資源的壓力並提高病患的依從性。使用配送套件和虛擬監測有效地將診斷過程與實體設施脫鉤。公共醫療保健系統正以大量資金支持這項後勤轉型。根據《健康科技新聞》2024年10月報道,蘇格蘭國民醫療服務體系(NHS Scotland)與Medtronic續簽了一項價值400萬英鎊的合作協議,以維持這些社區服務並縮短患者的等待時間。
The Global Endoscopy Capsule Market is projected to expand from USD 0.82 Billion in 2025 to USD 1.58 Billion by 2031, reflecting a compound annual growth rate of 11.55%. These devices are wireless, ingestible units fitted with miniature cameras that transmit images of the gastrointestinal tract, specifically the small bowel, as they move via natural peristalsis. Growth is driven by the rising prevalence of gastrointestinal conditions like Crohn's disease and obscure bleeding, alongside a shift in patient preference toward non-invasive options that do not require sedation. Highlighting the need for robust screening tools, the American Cancer Society estimated 152,810 new colorectal cancer cases in the United States in 2024, emphasizing the demand for accessible diagnostic solutions.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 0.82 Billion |
| Market Size 2031 | USD 1.58 Billion |
| CAGR 2026-2031 | 11.55% |
| Fastest Growing Segment | Colon |
| Largest Market | North America |
However, the market encounters significant hurdles due to high procedural costs and variable reimbursement policies, which may hinder widespread growth. In numerous regions, insurance coverage for capsule endoscopy is stricter than for conventional optical endoscopy, establishing financial obstacles in cost-sensitive markets. Consequently, the lack of uniform economic support compels providers and patients to depend on invasive alternatives, thereby limiting the technology's potential to become a primary global standard of care.
Market Driver
The incorporation of Artificial Intelligence and Machine Learning is transforming the Global Endoscopy Capsule Market by resolving the challenge of lengthy image reviews. Modern algorithms can swiftly process thousands of images recorded during the capsule's journey, differentiating between healthy tissue and potential irregularities with high accuracy. This technological advancement not only improves diagnostic precision but also eases the burden on gastroenterologists, facilitating mass adoption. As evidence of this progress, AnX Robotica's January 2024 press release regarding FDA clearance for ProScan noted that their deep learning model detected small bowel abnormalities with a per-patient sensitivity of 99.88%, confirming AI's role in enhancing gastrointestinal care.
Concurrently, government-sponsored cancer screening programs are driving market growth, especially in areas aiming to clear diagnostic backlogs. Public health bodies are increasingly integrating capsule endoscopy into national protocols as a less invasive substitute for traditional colonoscopy, which boosts patient participation and early detection. According to the World Health Organization, colorectal cancer represented about 9.6% of all global cancer cases in 2024, underscoring the need for such accessible screening methods. Illustrating this trend, UK Tech News reported in March 2024 that a West Midlands initiative aimed for 2,000 individuals to utilize colon capsule endoscopy technology in its inaugural year to accelerate diagnosis and shorten wait times.
Market Challenge
Significant impediments to the endoscopy capsule market's expansion include elevated procedural expenses and uneven reimbursement structures. Although the technology provides a non-invasive alternative, it often lacks the comprehensive insurance coverage afforded to traditional optical endoscopy, creating financial hurdles to broad utilization. Healthcare providers often face challenges obtaining authorization, resulting in payment uncertainty and higher costs for patients. This economic imbalance drives medical facilities to favor conventional methods with verified billing codes and assured payments, thereby restricting the routine clinical application of capsule technology.
These financial pressures are intensified by declining payment rates for gastroenterology services, which impact the commercial feasibility of new diagnostic tools. For instance, the American Gastroenterological Association reported in 2024 that the Centers for Medicare & Medicaid Services applied a 3.37 percent decrease to the Medicare physician fee schedule conversion factor, reducing overall reimbursement for GI procedures. Such cuts in funding dissuade clinics and budget-conscious health systems from adopting capsule endoscopy programs. As a result, market expansion is stifled as the economic climate supports established, less expensive diagnostic options.
Market Trends
The emergence of Magnetically Maneuverable Active Capsule Systems is transforming the market by overcoming the limitations of passive devices in visualizing complex stomach anatomy. Unlike standard capsules dependent on natural movement, these active systems employ external magnets or internal propulsion to grant physicians precise control, mimicking the maneuverability of gastroscopy without requiring sedation. This innovation is drawing substantial capital to speed up the creation of steerable ingestible robots. For example, The Robot Report stated in June 2024 that startup Endiatx raised $7 million to progress its robotic PillBot, enabling gastroenterologists to remotely guide the device for thorough gastric exams.
Simultaneously, the shift toward At-Home and Remote Capsule Endoscopy Service Models is decentralizing diagnostics, enabling patients to perform procedures at home instead of in clinics. This approach reduces strain on hospital resources and boosts patient compliance through the use of delivered kits and virtual monitoring, effectively detaching the diagnostic process from physical facilities. Public health systems are increasingly supporting this logistical change with significant funding; according to Health Tech News in October 2024, NHS Scotland renewed its partnership with Medtronic with a £4 million contract to maintain these community-based services and alleviate waiting times.
Report Scope
In this report, the Global Endoscopy Capsule Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Endoscopy Capsule Market.
Global Endoscopy Capsule Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: